Carcinoma ofprostate is the second most common cause of cancer death in men in the UK. It is known that patients with carcinoma of prostate are at significant risk of developing a second primary neoplasm.' These second primary are mainly colorectal, stomach or urinary bladder. The histopathology of gastrointestinal tumours is usually adenocarcinoma. We report a case of prostate cancer that developed an unusual combination of atrial myxoma, small bowel carcinoid, basal cell cancer on shoulder skin, rectosigmoid adenocarcinoma and caecal adenoma over a period of five years. CASE REPORT A 73 years old man presented with significant bladder outlet obstruction in 1996. On clinical examination he had a smooth enlarged prostate. The postate specific antigen (PSA) was elevated at 38.5ng/1. Transurethral resection of prostate was performed; 21gm of this was resected. The histopathology report was adenocarcinoma of prostate (Gleason score 3, in 90% of resected tissue). The staging CT scan was normal, and bone scan revealed a suspicious area of increased uptake near the right femoral metaphysis. The patient was started on hormonal treatment in the form of Goserelin injections. The serum PSA level returned to normal within 1 year and has remained within the normal range for 5 years. A bone scan repeated after 3 years was also normal.
In March 2001 the patient presented with vomiting and abdominal distension. X-ray showed features consistent with small bowel obstruction. An exploratory laprotomy was carried out. A small bowel tumour was identified with extensive mesenteric lymphadenopathy and was resected. Histopathology confirmed small bowel carcinoid. All the mesenteric lymph nodes were negative for metastases 
